Answers are grounded in this paper and cite their sources.
Leukocytoclastic vasculitis flare following the COVID-19 vaccine Dear Editor, Two messenger ribonucleic acid (mRNA) vaccines were authorized for emergency use by the United States Food and Drug Administration (U.S. FDA) against the Coronavirus Disease 2019 (COVID-19) at the end of 2020. 1 Immunization is a significant milestone in fighting this pandemic; however, safety regarding special populations has yet to be determined. We report a case of a patient who suffered from vasculitis after COVID-19 vaccination.
No takes yet. Share an insight, caveat, or question.
Cohen et al. (2021) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: